Elite in Brain Tumor

Dr. Ashley L. Sumrall

Hematology | Oncology
Atrium Health
Atrium Health Levine Cancer Institute (Medical Oncology & Immunotherapy)
1021 Morehead Medical Drive, Suite 6100, 
Charlotte, NC 
On Staff At
Accepting New Patients
Offers Telehealth
Elite in Brain Tumor
Atrium Health
Atrium Health Levine Cancer Institute (Medical Oncology & Immunotherapy)
1021 Morehead Medical Drive, Suite 6100, 
Charlotte, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ashley Sumrall is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Sumrall is rated as an Elite provider by MediFind in the treatment of Brain Tumor. Her top areas of expertise are Glioma, Brain Tumor, Astrocytoma, and Glioblastoma. Dr. Sumrall is currently accepting new patients.

Her clinical research consists of co-authoring 35 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 21 articles and participated in 3 clinical trials in the study of Brain Tumor.

Graduate Institution
The University Of Mississippi
Residency
The University of Mississippi
Specialties
Hematology
Oncology
Licenses
Internal Medicine in NC
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine, Medical Oncology
Fellowships
Duke University
Hospital Affiliations
Carolinas Medical Center-Northeast
Atrium Health Pineville
Carolinas Medical Center/behav Health
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Atrium Health Levine Cancer Institute (Medical Oncology & Immunotherapy)
1021 Morehead Medical Drive, Suite 6100, Charlotte, NC 28204
Call: 980-442-5310

Additional Areas of Focus

Dr. Sumrall has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Pituitary Tumor
Thyroid Cancer
Neurofibromatosis Type 1 (NF1)
Ovarian Cancer
Breast Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Genomically-Guided Treatment Trial in Brain Metastases
Genomically-Guided Treatment Trial in Brain Metastases
Enrollment Status: Suspended
Publish Date: December 12, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Paxalisib, Entrectinib
Study Phase: Phase 2
Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: October 02, 2025
Intervention Type: Other, Biological, Procedure, Drug, Radiation, Device
Study Drugs: Ipilimumab, Nivolumab, Temozolomide
Study Phase: Phase 2/Phase 3
A Phase II, Open-label Study of ONC201 in Adults With Recurrent High-grade Glioma
A Phase II, Open-label Study of ONC201 in Adults With Recurrent High-grade Glioma
Enrollment Status: Terminated
Publish Date: July 28, 2025
Intervention Type: Drug
Study Drug: ONC201
Study Phase: Phase 2
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
A Randomized, Placebo Controlled Phase 3 Study of ABT-414 With Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance1)
A Randomized, Placebo Controlled Phase 3 Study of ABT-414 With Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance1)
Enrollment Status: Completed
Publish Date: May 11, 2023
Intervention Type: Drug, Radiation
Study Drugs: Temozolomide, Depatuxizumab
Study Phase: Phase 3
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug, Other
Study Phase: Phase 2
View 6 Less Clinical Trials

35 Total Publications

Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Journal: Cancer discovery
Published: January 30, 2025
View All 35 Publications
Similar Doctors
Daniel E. Haggstrom
Distinguished in Brain Tumor
Dr. Daniel E. Haggstrom
Hematology | Oncology
Distinguished in Brain Tumor
Dr. Daniel E. Haggstrom
Hematology | Oncology

Atrium Health Levine Cancer Institute (Thoracic-Pulmonary)

1021 Morehead Medical Drive, Building 2, Suite 30500, 
Charlotte, NC 
 (0.1 miles away)
980-442-3300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Haggstrom is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Haggstrom is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Haggstrom is currently accepting new patients.

Advanced in Brain Tumor
Dr. Eugene H. Paschold
Oncology | Hematology Oncology
Advanced in Brain Tumor
Dr. Eugene H. Paschold
Oncology | Hematology Oncology
1370 Piedmont Dr, Suite 202, 
Lexington, NC 
 (55.7 miles away)
336-249-6632
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Eugene Paschold is an Oncologist and a Hematologist Oncology provider in Lexington, North Carolina. Dr. Paschold is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Posterior Fossa Tumor. Dr. Paschold is currently accepting new patients.

David A. Gass
Experienced in Brain Tumor
Dr. David A. Gass
Hematology | Oncology
Experienced in Brain Tumor
Dr. David A. Gass
Hematology | Oncology

Atrium Health Levine Children’s Cancer & Blood Disorders, A Facility Of Carolinas Medical Center

1001 Blythe Blvd., Suite 3000, 
Charlotte, NC 
 (0.1 miles away)
704-381-9900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Gass is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Gass is rated as an Experienced provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Brain Tumor, Brain Stem Cancer, Agranulocytosis, and Glioma. Dr. Gass is currently accepting new patients.

VIEW MORE BRAIN TUMOR DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sumrall's expertise for a condition
ConditionClose
  • Elite
  • Brain Tumor
    Dr. Sumrall is
    Elite
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Glioma
    Dr. Sumrall is
    Elite
    . Learn about Glioma.
    See more Glioma experts
  • Distinguished
  • Astrocytoma
    Dr. Sumrall is
    Distinguished
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Atypical Teratoid Rhabdoid Tumor (ATRT)
    Dr. Sumrall is
    Distinguished
    . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
    See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
  • Embryonal Tumor with Multilayered Rosettes
    Dr. Sumrall is
    Distinguished
    . Learn about Embryonal Tumor with Multilayered Rosettes.
    See more Embryonal Tumor with Multilayered Rosettes experts
  • Ependymoma
    Dr. Sumrall is
    Distinguished
    . Learn about Ependymoma.
    See more Ependymoma experts
  • Glioblastoma
    Dr. Sumrall is
    Distinguished
    . Learn about Glioblastoma.
    See more Glioblastoma experts
  • Gliomatosis Cerebri
    Dr. Sumrall is
    Distinguished
    . Learn about Gliomatosis Cerebri.
    See more Gliomatosis Cerebri experts
View All 13 Distinguished Conditions
  • Advanced
  • Brain Stem Cancer
    Dr. Sumrall is
    Advanced
    . Learn about Brain Stem Cancer.
    See more Brain Stem Cancer experts
  • Breast Cancer
    Dr. Sumrall is
    Advanced
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • Dysembryoplastic Neuroepithelial Tumors (DNET)
    Dr. Sumrall is
    Advanced
    . Learn about Dysembryoplastic Neuroepithelial Tumors (DNET).
    See more Dysembryoplastic Neuroepithelial Tumors (DNET) experts
  • Inflammatory Breast Cancer
    Dr. Sumrall is
    Advanced
    . Learn about Inflammatory Breast Cancer.
    See more Inflammatory Breast Cancer experts
  • Langerhans Cell Histiocytosis
    Dr. Sumrall is
    Advanced
    . Learn about Langerhans Cell Histiocytosis.
    See more Langerhans Cell Histiocytosis experts
  • Non-Hodgkin Lymphoma
    Dr. Sumrall is
    Advanced
    . Learn about Non-Hodgkin Lymphoma.
    See more Non-Hodgkin Lymphoma experts
View All 8 Advanced Conditions
  • Experienced
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Sumrall is
    Experienced
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
  • Anaplastic Thyroid Cancer
    Dr. Sumrall is
    Experienced
    . Learn about Anaplastic Thyroid Cancer.
    See more Anaplastic Thyroid Cancer experts
  • Angiosarcoma
    Dr. Sumrall is
    Experienced
    . Learn about Angiosarcoma.
    See more Angiosarcoma experts
  • Cerebral Ventricle Cancer
    Dr. Sumrall is
    Experienced
    . Learn about Cerebral Ventricle Cancer.
    See more Cerebral Ventricle Cancer experts
  • Colorectal Cancer
    Dr. Sumrall is
    Experienced
    . Learn about Colorectal Cancer.
    See more Colorectal Cancer experts
  • Desmoid Tumor
    Dr. Sumrall is
    Experienced
    . Learn about Desmoid Tumor.
    See more Desmoid Tumor experts
View All 34 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.